Fig. 1From: Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practiceChange in seizure frequency in patients with epilepsy (n = 45). *Clinically relevant reduction without a given percentage (when percentage change was not available)Back to article page